MALLINCKRODT FDA Approval ANDA 075738

ANDA 075738

MALLINCKRODT

FDA Drug Application

Application #075738

Documents

Letter2001-02-02

Application Sponsors

ANDA 075738MALLINCKRODT

Marketing Status

Discontinued001

Application Products

001TABLET;ORAL650MG;100MG0PROPOXYPHENE NAPSYLATE AND ACETAMINOPHENACETAMINOPHEN; PROPOXYPHENE NAPSYLATE

FDA Submissions

ORIG1AP2001-02-02
MANUF (CMC); Manufacturing (CMC)SUPPL2AP2002-12-03
MANUF (CMC); Manufacturing (CMC)SUPPL3AP2002-12-03
LABELING; LabelingSUPPL4AP2002-12-03

Submissions Property Types

ORIG1Null0
SUPPL2Null0
SUPPL3Null0
SUPPL4Null0

CDER Filings

MALLINCKRODT
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 75738
            [companyName] => MALLINCKRODT
            [docInserts] => ["",""]
            [products] => [{"drugName":"PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN","activeIngredients":"ACETAMINOPHEN; PROPOXYPHENE NAPSYLATE","strength":"650MG;100MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN","submission":"ACETAMINOPHEN; PROPOXYPHENE NAPSYLATE","actionType":"650MG;100MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.